Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- Scopus Q3
- 저널
- TUMOR BIOLOGY37(2) · pp.2285 · 2016
- 피인용
- Web of Science 16
- JCR IF
- JCR 2015 2.926
- ISSN
- 1010-4283
저자
- Lee, Young Seok제1저자Department of Biochemistry, School of Medicine, Konkuk University, Seoul, South Korea
- Hwang, Sun GooPlant Genomics Laboratory, Department of Applied Plant Science, Kangwon National University, Chuncheon, South Korea
- Kim, Jin KiDepartment of Biochemistry, School of Medicine, Konkuk University, Seoul, South Korea
- Park, Tae HwanDepartment of Plastic and Reconstructive Surgery, College of Medicine, Yonsei University, Seoul, South Korea
- Kim, Young RaeDepartment of Biochemistry, School of Medicine, Konkuk University, Seoul, South Korea
- Myeong, Ho SungDepartment of Biochemistry, School of Medicine, Konkuk University, Seoul, South Korea
- Choi, Jong DuckDepartment of Biochemistry, School of Medicine, Konkuk University, Seoul, South Korea
- 권강School of Korean Medicine, Pusan National University, Yangsan, South Korea
- Jang, Cheol SeongPlant Genomics Laboratory, Department of Applied Plant Science, Kangwon National University, Chuncheon, South Korea
- Ro, Young TaeDepartment of Biochemistry, School of Medicine, Konkuk University, Seoul, South Korea
- Noh, Yun HeeDepartment of Biochemistry, School of Medicine, Konkuk University, Seoul, South Korea
- Kim, Sung Young교신저자Department of Biochemistry, School of Medicine, Konkuk University, Seoul, South Korea
초록
Acquired resistance to lapatinib is a highly problematic clinical barrier that has to be overcome for a successful cancer treatment. Despite efforts to determine the mechanisms underlying acquired lapatinib resistance (ALR), no definitive genetic factors have been reported to be solely responsible for the acquired resistance in breast cancer. Therefore, we performed a cross-platform meta-analysis of three publically available microarray datasets related to breast cancer with ALR, using the R-based RankProd package. From the meta-analysis, we were able to identify a total of 990 differentially expressed genes (DEGs, 406 upregulated, 584 downregulated) that are potentially associated with ALR. Gene ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the DEGs showed that "response to organic substance" and "p53 signaling pathway" may be largely involved in ALR process. Of these, many of the top 50 upregulated and downregulated DEGs were found in oncogenesis of various tumors and cancers. For the top 50 DEGs, we constructed the gene coexpression and protein-protein interaction networks from a huge database of well-known molecular interactions. By integrative analysis of two systemic networks, we condensed the total number of DEGs to six common genes (LGALS1, PRSS23, PTRF, FHL2, TOB1, and SOCS2). Furthermore, these genes were confirmed in functional module eigens obtained from the weighted gene correlation network analysis of total DEGs in the microarray datasets ("GSE16179" and "GSE52707"). Our integrative meta-analysis could provide a comprehensive perspective into complex mechanisms underlying ALR in breast cancer and a theoretical support for further chemotherapeutic studies.
키워드
Meta-analysisMicroarrayDifferentially expressed genesBreast cancerAcquired lapatinib resistanceRECEPTOR TYROSINE KINASESGROWTH-FACTOR RECEPTORMULTIDRUG-RESISTANCEPROSTATE-CANCERCELLSACTIVATIONPATHWAYSSUPPRESSESSTRATEGIESINHIBITORS
식별자
- WoS UID
- 000374593300096



로그인
연구물 목록으로